Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)

v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative adjustment from adoption of ASC 326
Arbuz Group LLP ("Arbuz")
ReKassa
Total equity attributable to the shareholders'
Total equity attributable to the shareholders'
Cumulative adjustment from adoption of ASC 326
Total equity attributable to the shareholders'
Arbuz Group LLP ("Arbuz")
Common Stock
Additional paid in capital
Retained earnings
Retained earnings
Cumulative adjustment from adoption of ASC 326
Retained earnings
Arbuz Group LLP ("Arbuz")
Accumulated other comprehensive loss
Non- controlling interest
Non- controlling interest
Arbuz Group LLP ("Arbuz")
Non- controlling interest
ReKassa
Beginning balance (in shares) at Mar. 31, 2023               59,659,191                
Equity, beginning of period at Mar. 31, 2023 $ 770,736 $ (22,772)     $ 777,285 $ (22,772)   $ 59 $ 164,162 $ 647,064 $ (22,772)   $ (34,000) $ (6,549)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock based compensation 3,303       3,303       3,303              
Disposal of FF Ukraine 0       (6,549)         (6,549)       6,549    
Purchase of subsidiary shares     $ 9,097 $ 256     $ 5,457         $ 5,457     $ 3,640 $ 256
Foreign currency translation adjustments, net of tax effect (3,593)       (3,593)               (3,593)      
Other comprehensive income 2,748       2,748               2,748      
Net income/(loss) 279,475       280,317         280,317       (842)    
Ending balance (in shares) at Dec. 31, 2023               59,659,191                
Equity, end of period at Dec. 31, 2023 1,039,250       1,036,196     $ 59 167,465 903,517     (34,845) 3,054    
Beginning balance (in shares) at Sep. 30, 2023               59,659,191                
Equity, beginning of period at Sep. 30, 2023 914,431       911,084     $ 59 166,426 807,149     (62,550) 3,347    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock based compensation 1,039       1,039       1,039              
Foreign currency translation adjustments, net of tax effect 28,100       28,100               28,100      
Other comprehensive income (395)       (395)               (395)      
Net income/(loss) 96,075       96,368         96,368       (293)    
Ending balance (in shares) at Dec. 31, 2023               59,659,191                
Equity, end of period at Dec. 31, 2023 $ 1,039,250       1,036,196     $ 59 167,465 903,517     (34,845) 3,054    
Beginning balance (in shares) at Mar. 31, 2024 60,321,813             60,321,813                
Equity, beginning of period at Mar. 31, 2024 $ 1,166,958       1,163,650     $ 60 183,788 998,740     (18,938) 3,308    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Delivered stock based compensation from previous quarter (in shares)               215,878                
Delivered stock based compensation from previous quarter 3,092       3,092       3,092              
Forfeited stock based compensation (in shares)               (310,700)                
Forfeited stock based compensation 0                              
Stock based compensation (in shares)               392,226                
Stock based compensation 36,089       36,089     $ 1 36,088              
Foreign currency translation adjustments, net of tax effect (186,990)       (186,990)               (186,990)      
Other comprehensive income 16,712       16,712               16,712      
Net income/(loss) $ 226,884       227,339         227,339       (455)    
Ending balance (in shares) at Dec. 31, 2024 60,619,217             60,619,217                
Equity, end of period at Dec. 31, 2024 $ 1,262,745       1,259,892     $ 61 222,968 1,226,079     (189,216) 2,853    
Beginning balance (in shares) at Sep. 30, 2024               60,557,801                
Equity, beginning of period at Sep. 30, 2024 1,263,236       1,260,239     $ 61 209,249 1,147,798     (96,869) 2,997    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Delivered stock based compensation from previous quarter (in shares)               12,816                
Delivered stock based compensation from previous quarter $ 302       302       302              
Stock based compensation (in shares) 48,600             48,600                
Stock based compensation $ 13,417       13,417       13,417              
Foreign currency translation adjustments, net of tax effect (101,212)       (101,212)               (101,212)      
Other comprehensive income 8,865       8,865               8,865      
Net income/(loss) $ 78,137       78,281         78,281       (144)    
Ending balance (in shares) at Dec. 31, 2024 60,619,217             60,619,217                
Equity, end of period at Dec. 31, 2024 $ 1,262,745       $ 1,259,892     $ 61 $ 222,968 $ 1,226,079     $ (189,216) $ 2,853